Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CX-157 (KP 157) is a novel monoamine oxidase-A (MAO-A) inhibitor for the study of depression-like neurological disorders and cancer.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 67,500 |
5 mg | 在庫あり | ¥ 166,000 |
10 mg | 在庫あり | ¥ 226,500 |
25 mg | 在庫あり | ¥ 349,000 |
50 mg | 在庫あり | ¥ 454,500 |
説明 | CX-157 (KP 157) is a novel monoamine oxidase-A (MAO-A) inhibitor for the study of depression-like neurological disorders and cancer. |
ターゲット&IC50 | MAO-A:(EC50)19.3 ng/ml, MAO-A:19.3 ng/ml(EC50) |
In vivo | CX157 (60 and 80 mg) significantly inhibited the binding of [(11)C]clorgyline to brain MAO-A by 47-72% at 2 hours post-administration, with complete recovery of brain MAO-A by 24 hours post-dosing[1]. |
別名 | KP 157 |
分子量 | 348.27 |
分子式 | C14H8F4O4S |
CAS No. | 205187-53-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CX-157 205187-53-7 Metabolism Neuroscience MAO KP 157 CX157 CX 157 Inhibitor inhibitor inhibit